ATE196989T1 - Inhalationszusammensetzungmit lactosegranulate - Google Patents

Inhalationszusammensetzungmit lactosegranulate

Info

Publication number
ATE196989T1
ATE196989T1 AT95913091T AT95913091T ATE196989T1 AT E196989 T1 ATE196989 T1 AT E196989T1 AT 95913091 T AT95913091 T AT 95913091T AT 95913091 T AT95913091 T AT 95913091T AT E196989 T1 ATE196989 T1 AT E196989T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
inhalation
lactose
inhalation composition
lactose granules
Prior art date
Application number
AT95913091T
Other languages
English (en)
Inventor
Gerald Wynn Hallworth
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10751813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE196989(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE196989T1 publication Critical patent/ATE196989T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95913091T 1994-03-15 1995-03-13 Inhalationszusammensetzungmit lactosegranulate ATE196989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9404945A GB9404945D0 (en) 1994-03-15 1994-03-15 Pharmaceutical composition
PCT/EP1995/000917 WO1995024889A1 (en) 1994-03-15 1995-03-13 Inhalation composition containing lactose pellets

Publications (1)

Publication Number Publication Date
ATE196989T1 true ATE196989T1 (de) 2000-11-15

Family

ID=10751813

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913091T ATE196989T1 (de) 1994-03-15 1995-03-13 Inhalationszusammensetzungmit lactosegranulate

Country Status (12)

Country Link
US (2) US6183782B1 (de)
EP (1) EP0750492B1 (de)
AT (1) ATE196989T1 (de)
AU (1) AU2068995A (de)
DE (1) DE69519157T2 (de)
DK (1) DK0750492T3 (de)
ES (1) ES2152394T3 (de)
GB (1) GB9404945D0 (de)
GR (1) GR3034845T3 (de)
PT (1) PT750492E (de)
WO (1) WO1995024889A1 (de)
ZA (1) ZA952049B (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
SE9700135D0 (sv) † 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
EP0876814A1 (de) 1997-05-07 1998-11-11 "PHARLYSE", Société Anonyme Trägerstoff für Trockenpulverinhalator, Verfahren zu dessen Herstellung und diesen enthaltende Arzneimittel
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
GB9807232D0 (en) * 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
DE19921693A1 (de) 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
EA006384B1 (ru) * 2000-07-31 2005-12-29 Нюкомед Данмарк А/С Композиция фентанила для интраназального введения
AU2001278115A1 (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
TR200402367T4 (tr) * 2000-10-12 2004-12-21 Boehringer Ingelheim Pharma Gmbh& Co.Kg Yeni tiotropyum içeren inhalasyon tozları
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
AU2002308143A1 (en) * 2002-04-12 2003-10-27 Campina Nederland Holding B.V. Excipient for use in dry powder inhalation preparations
SI1531794T1 (sl) * 2002-06-28 2017-12-29 Civitas Therapeteutics, Inc. Epinefrin za vdihavanje
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
JP2007505136A (ja) * 2003-09-10 2007-03-08 マツプ・フアーマシユーテイカルズ・インコーポレーテツド ジヒドロエルゴタミンを肺吸入により体循環に送達するためのエアゾール製剤
JP2007509941A (ja) * 2003-10-28 2007-04-19 グラクソ　グループ　リミテッド ラクトース無水物を用いる吸入医薬製剤およびその投与方法
MX2007009656A (es) 2005-02-10 2007-11-07 Glaxo Group Ltd Proceso para elaborar lactosa utilizando tecnicas de clasificacion previa y formulaciones farmaceuticas formadas de la misma.
EP1944018A1 (de) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Mikronisierte Partikel mit niedrigdosierten Wirkstoffen für Pulverzubereitungen zur Inhalation
WO2008097664A1 (en) * 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
EP1964564A1 (de) * 2007-04-19 2008-09-03 LAB International SRL Durchbruchsschmerzbehandlung
US8415390B2 (en) * 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
EP2100598A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
WO2010151804A1 (en) * 2009-06-26 2010-12-29 Map Pharmaceuticals, Inc. Administration of dihydroergotamine mesylate particles using a metered dose inhaler
TR200909791A2 (tr) * 2009-12-25 2011-07-21 B�Lg�� Mahmut Salmeterol ve flutikazon içeren farmasötik bileşim@
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
EP2821061B1 (de) 2013-07-01 2017-12-20 Arven Ilac Sanayi Ve Ticaret A.S. Neue präparate fur atemwege
US10583085B2 (en) * 2017-05-17 2020-03-10 Chiesi Farmaceutici S.P.A. Carrier particles for dry powder formulations for inhalation
SI3781126T1 (sl) 2018-04-16 2022-10-28 Ioulia Tseti Farmacevtska sestava suhih praškov za inhalacijo, ki vsebujejo ščitnični hormon
CA3150240A1 (en) 2019-09-24 2021-04-01 Tomaso GUIDI Dry powder formulation for a dry powder inhaler, with a combination of spheronised particles and coarse particles, and a dry powder inhaler comprising the formulation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB398631A (en) 1932-07-28 1933-09-21 Fredk Thomas & Company Ltd Improvements in and connected with lamp-shades
US2897119A (en) * 1957-11-12 1959-07-28 Camp Sea Food Company Inc Van Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
US3341415A (en) * 1964-02-12 1967-09-12 Warner Lambert Pharmaceutical Pharmaceutical tablet excipients of solid particles of a binary solid solution of mannitol with a sugar
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
BE787066A (fr) 1971-08-03 1973-02-01 Beecham Group Ltd Compositions pharmaceutiques comprenant de la 2-nitroindane-1,3-dione
GB1410588A (en) 1971-08-10 1975-10-22 Fisons Ltd Composition
GB1478020A (en) 1973-09-14 1977-06-29 Beecham Group Ltd Composition for the treatment of asthma
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB1571629A (en) 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
DE3326089A1 (de) 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
ES2044710T3 (es) 1990-01-29 1994-01-01 Ciba Geigy Ag Procedimiento y dispositivo de dosificacion de un polvo de granulometria fina.
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
PT721331E (pt) * 1993-10-01 2002-05-31 Astrazeneca Ab Processo i
GB9404945D0 (en) * 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物

Also Published As

Publication number Publication date
DE69519157D1 (de) 2000-11-23
WO1995024889A1 (en) 1995-09-21
DE69519157T2 (de) 2001-08-09
PT750492E (pt) 2001-03-30
EP0750492A1 (de) 1997-01-02
DK0750492T3 (da) 2000-12-18
AU2068995A (en) 1995-10-03
EP0750492B1 (de) 2000-10-18
ZA952049B (en) 1995-12-21
ES2152394T3 (es) 2001-02-01
US6183782B1 (en) 2001-02-06
GR3034845T3 (en) 2001-02-28
GB9404945D0 (en) 1994-04-27
US6955824B1 (en) 2005-10-18

Similar Documents

Publication Publication Date Title
ATE196989T1 (de) Inhalationszusammensetzungmit lactosegranulate
AU4260496A (en) Propellant mixture for aerosol formulation
SE9701956D0 (sv) New composition of matter
MY108748A (en) Medicaments
ES2164097T3 (es) Uso de anestesicos topicos para la fabricacion de un medicamento para el tratamiento del asma bronquial.
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
MX9605650A (es) Formulaciones de propionato de fluticasona.
IE821453L (en) Oral dipyridamole preparations
HUT77927A (hu) Nebivolol-származékok alkalmazása antiatherogén hatású gyógyászati készítmények előállítására és e vegyületeket tartalmazó kombinációs gyógyászati készítmények
RU93058261A (ru) Гетероциклические амины, используемые в терапии астмы и воспаления респираторного тракта
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
CA2150184A1 (en) Pharmaceutical composition for the treatment of inflammatory bowel diseases
CA2166332A1 (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
CA2150183A1 (en) Pharmaceutical composition for the treatment of hemorrhoidal diseases
WO1996005836A3 (en) Methods of treating cold symptoms using pentoxifylline
EP1101493A3 (de) Neue Verwendung von Budesonide und Formoterol
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
JPS5585526A (en) Remedy for allergic disease
ES2109347T3 (es) Utilizacion en terapeutica de picnogenoles para la preparacion de medicamentos con actividad anti-inflamatoria.
Ohgushi et al. Clinical Experience of Disodium Cromoglycate Eye Drops in the Treatment of Allergic Eye Diseases.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked
RZN Patent revoked